Trial intelligence / Profile preview

CHONDROSULF oral gel versus capsules versus placebo in knee osteoarthritis

2005-005163-29Phase 3Completed

Sponsor
IBSA Group
Start
Feb 2006
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of chondroitin sulfate in knee osteoarthritis (OA) (3 arms), sponsored by IBSA Group. Primary endpoints: Primary efficacy endpoint and Safety endpoint. Started Feb 2006; status: completed.

02

Drugs

chondroitin sulfate
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2005-005163-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005163-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call